NIAID, biggest entity under NIH.
Jeffry Morris of the University of Pennsylvania was all over Twitter defending the vaccines was basically an agent claiming that, no, he doesn't have any stock in pharma. U of Penn is one of the largest recipients of grant funding. He was lying the entire time. He's still a professor there. So you go to Mass General Hospital is 7th in funding. At the bottom of this sheet, you see Mass. General Brigham. They're listed separately, but if you add them up, it's $1.12 billion and it blows Johns Hopkins. It's by far the biggest grant-funded institution in the world, the National Institutes of Health,
Mass General Brigham had a 47.1% growth in revenue. Where'd they get the extra $6.6 billion in 5 years? This doesn't happen in a growth industry, except for maybe cell phones in the 1990s. Oh, they had a 47% growth rate. Yeah, because they're getting them cheap, and everybody's getting them. That's not healthcare. This is all funny money from the federal government. I don't really care about profit and loss, because they're a non-profit and they just move money around to either make money or lose money that year or the year after. But because they're a non-profit, they have to balance the books. But the research and academic money in that thin column right there, it's a 41% growth over 5 years, 2.06 to 2.9, we're looking at 2.9 billion dollars in research and academic money coming into Mass. General Brigham.
And then Medicaid: 65% growth in Medicaid income that they're receiving from 2019 to 2024. $781 million grew to $2.9 billion. And then Medicare: $2.9 billion up to $4.11 billion.
Here's an interesting one. Massachusetts Managed Care. So before there was Obamacare, there was Romneycare. That was our governor. Sorry, United States, but where do you think Obamacare came from? It was Massachusetts. They make all this stuff. So that plan cost the state, cost the taxpayers, $4.7 billion. Sorry, we paid Mass General Brigham, we paid, the taxpayers of Massachusetts Mass General Brigham $4.71 billion in 2024. Their total revenue is $20 billion. They're getting $4 billion from Mass, almost $5 billion. $4 billion from Medicare. $1.3 billion from Medicaid. $2.9 billion from research grants and stuff like that. Is this a hospital? I don't even know what I'm looking at here. This is the government. We're looking at a government, a state actor. $4.28 billion, oh, it's NIH funding, so 43% growth over 5 years, and then it went from $1 billion to 4.55 billion.
Now, let's look at the big one, way over to the right, "Specialty & Retail Pharmacy Operations" at a hospital. They did $179 million in 2019, and it was $228 million in 2020 but think about COVID. COVID came in in March, and the fiscal years we're looking at are September 30 end. So any time you're looking at year it's ended September 30 fiscal year. So COVID was only around for 6 months, basically one wave in 2020 in that one number that's $228 million. It's still phenomenal growth. You're still looking at . . . I don't want to run the numbers in my head here. It's 60% to 70% growth, I have no idea. But you look at 576% up to $1.2 billion in 2024. You gotta ask, "What's going on?" How are they using so many specialty drugs in just 5 years? What is the incentive, or was the incentive the reason why they're using so many? If you incentivize something, you will get more of it. Walter E. Williams. I loved that guy. Yeah, we lost him during COVID too.
